Satoru Kitazono

6PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2025
Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC.

Satoru Kitazono, Akira Ono, Tetsuji Kawamura

|Sep 09, 2024
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.

Myung-Ju Ahn, Kentaro Tanaka, Luis Paz-Ares

|Dec 27, 2022
Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice.

Izuma Nakayama, Eiji Shinozaki, Hiroshi Kawachi

|May 07, 2021
Characteristics of central nervous system progression in non-small cell lung cancer treated with crizotinib or alectinib.

Hiroaki Sakamoto, Noriko Yanagitani, Ryo Manabe

|Aug 20, 2020
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma.

Yusuke Okuma, Yasushi Goto, Fumiyoshi Ohyanagi

|Jan 26, 2019
First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors.

Akihiko Shimomura, Noboru Yamamoto, Shunsuke Kondo

Pageof 1